Nektar Therapeutics (NKTR)
37.60
+2.24
(+6.33%)
USD |
NASDAQ |
Jan 16, 16:00
37.70
+0.10
(+0.27%)
After-Hours: 20:00
Nektar Therapeutics SG&A Expense (TTM): 74.62M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 115.43M |
| Insmed, Inc. | 631.20M |
| Eli Lilly & Co. | 10.39B |
| Ironwood Pharmaceuticals, Inc. | 96.29M |
| Lyell Immunopharma, Inc. | 49.04M |